{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:17Z","timestamp":1793442677331,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471375"],"award-info":[{"award-number":["32471375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22205201"],"award-info":[{"award-number":["22205201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0508000"],"award-info":[{"award-number":["2023ZD0508000"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR26C100001"],"award-info":[{"award-number":["LR26C100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["2025SDXT002"],"award-info":[{"award-number":["2025SDXT002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115386","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:09:54Z","timestamp":1790035794000},"page":"115386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Tailoring lipid nanoparticles for application-specific mRNA delivery"],"prefix":"10.1016","volume":"399","author":[{"given":"Xinxin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115386_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41563-025-02320-9","article-title":"Tissue-specific mRNA delivery and prime editing with peptide-ionizable lipid nanoparticles","volume":"25","author":"Lin","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0015","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115386_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115386_bb0025","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115386_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-025-09873-4","article-title":"Transient hepatic reconstitution of trophic factors enhances aged immunity","volume":"650","author":"Friedrich","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115386_bb0040","first-page":"273","article-title":"\u03b2-Catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model","volume":"39","author":"Nelson","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0045","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115386_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115386_bb0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.adu9394","article-title":"Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction","volume":"391","author":"Zhang","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115386_bb0065","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41563-025-02284-w","article-title":"Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation","volume":"24","author":"Feng","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0070","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115386_bb0075","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cell.2026.01.012","article-title":"LUMI-lab: a foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery","volume":"189","author":"Xu","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115386_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41586-026-10158-7","article-title":"Pancreatic-targeted lipid nanoparticles based on organ capsule filtration","volume":"652","author":"Lei","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115386_bb0085","doi-asserted-by":"crossref","first-page":"28665","DOI":"10.1021\/jacs.5c01389","article-title":"Carbonate-bearing ionizable lipids for mRNA delivery to splenic NK cells","volume":"147","author":"Wu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115386_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.110833","article-title":"Tetra-branched ionizable lipids enhance the stability and transfection efficiency of lipid nanoparticles for mRNA delivery","volume":"36","author":"Xu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115386_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115386_bb0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115386_bb0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"npj Vaccin."},{"key":"10.1016\/j.jconrel.2026.115386_bb0110","doi-asserted-by":"crossref","first-page":"20230147","DOI":"10.1002\/EXP.20230147","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115386_bb0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-025-09655-y","article-title":"SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade","volume":"647","author":"Grippin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115386_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12116","article-title":"Principles of lipid nanoparticle design for mRNA delivery","volume":"3","author":"Zhang","year":"2025","journal-title":"BMEMat"},{"key":"10.1016\/j.jconrel.2026.115386_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100996","article-title":"Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches","volume":"14","author":"Maharjan","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.115386_bb0130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-025-67674-9","article-title":"Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy","volume":"17","author":"Gu","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115386_bb0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0140","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41565-025-02045-5","article-title":"A modular mRNA platform for programmable induction of tumour-specific immunogenic cell death","volume":"20","author":"Dong","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198943","article-title":"Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages","volume":"13","author":"Taciak","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115386_bb0150","first-page":"4970","article-title":"Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice","volume":"45","author":"Benard","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115386_bb0155","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1021\/jacs.5c16971","article-title":"Aromatic ionizable lipids enhance mRNA delivery via coordinating multiple mechanisms","volume":"148","author":"Lin","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115386_bb0160","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0165","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41565-025-01980-7","article-title":"Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles","volume":"20","author":"Liu","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0170","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1039\/D5TB00117J","article-title":"Injection site-retained lipid nanoparticles for targeted intramuscular delivery of mRNA RSV prefusion-F vaccine","volume":"13","author":"Chen","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115386_bb0175","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1039\/D1CS00617G","article-title":"Emerging mRNA technologies: delivery strategies and biomedical applications","volume":"51","author":"Xiao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115386_bb0180","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s44222-024-00198-x","article-title":"Engineering cells for therapy and diagnosis","volume":"2","author":"Li","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s44222-024-00268-0","article-title":"Organoid bioprinting: from cells to functional tissues","volume":"3","author":"Huang","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0190","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1038\/s41467-026-73698-6","article-title":"Polypeptide-engineered lipid nanoparticles for mRNA delivery with limited immunogenicity","volume":"17","author":"Zeng","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115386_bb0195","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115386_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102499","article-title":"Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery","volume":"81","author":"Zhao","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","article-title":"Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery","volume":"7","author":"Rhym","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","article-title":"Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity","volume":"8","author":"Zhu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0215","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","article-title":"Designing lipid nanoparticles using a transformer-based neural network","volume":"20","author":"Chan","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115386_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-026-02623-5","article-title":"Nanotechnology-mediated precision delivery of mRNA","author":"Deng","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115386_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-026-01640-8","article-title":"Artificial intelligence-guided design of LNPs for in vivo targeted mRNA delivery via analysis of the spatial conformation of ionizable lipids","author":"Su","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0230","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115386_bb0235","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s11427-024-2697-3","article-title":"Lipid nanoparticle-mediated base-editing of the Hao1 gene achieves sustainable primary hyperoxaluria type 1 therapy in rats","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2026.115386_bb0240","doi-asserted-by":"crossref","first-page":"eadv2293","DOI":"10.1126\/scitranslmed.adv2293","article-title":"Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD","volume":"17","author":"Yu","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115386_bb0245","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s44222-026-00424-8","article-title":"Expanding global access to mRNA vaccines","volume":"4","author":"Eshaghi","year":"2026","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115386_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aec7827","article-title":"A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle-based mRNA vaccines","volume":"12","author":"Muro","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115386_bb0255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mattod.2026.01.004","article-title":"Phospholipids tailor mRNA lipid nanoparticle delivery efficacy and immunogenicity","volume":"92","author":"Shi","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115386_bb0260","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115386_bb0265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115386_bb0270","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient targeting and activation of antigen presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115386_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115386_bb0280","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115386_bb0285","doi-asserted-by":"crossref","first-page":"22008","DOI":"10.1021\/acsnano.6c07039","article-title":"Decoding the functional roles of individual components in mRNA lipid nanoparticles","volume":"20","author":"Su","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115386_bb0290","doi-asserted-by":"crossref","first-page":"33058","DOI":"10.1021\/acsnano.4c08490","article-title":"Distinct inflammatory programs underlie the intramuscular lipid nanoparticle response","volume":"18","author":"Dowell","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115386_bb0295","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1039\/D2BM01581A","article-title":"Lipid nanoparticle-based mRNA candidates elicit potent T cell responses","volume":"11","author":"Zeng","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115386_bb0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/acsnanomed.5c00032","article-title":"Engineering delivery technologies for optimizing mRNA vaccines","volume":"1","author":"Gu","year":"2026","journal-title":"ACS Nano Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600790X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600790X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:44:05Z","timestamp":1793439845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592600790X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":60,"alternative-id":["S016836592600790X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115386","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailoring lipid nanoparticles for application-specific mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115386"}}